opening the letter…
Every venture capital firm we hold for Luxembourg, with stage focus, sector focus, cheque range and website.
113 firms · page 2 of 3
We are an emerging private equity fund focused on founders that create extraordinary online enterprises.
European VC investing in early-stage therapeutics, medtech, and bio-IT companies in the US and Europe
EIF-HBOR initiative to catalyze SME and midcap PE investments and build local fund manager capacity.
We invest between €2 and €10 million as an initial commitment, with follow-on investments possible
SEC exempt reporting adviser advising solely venture capital funds (Rule 203(l)-1 exemption).
Leading early-stage VC in Turkey; portfolio includes growth-stage B2B & industrial startups.
You are using an outdated browser. Please upgrade your browser to improve your experience.
Madrid based firm. Have not done a new deal since 2010 (I believe), last fund was 2005.
SGH Capital operates as a platform of funds that supports technology driven companies.
Luxempart is a leading investment company listed on the Luxembourg Stock Exchange.
Hiro Capital is a tech VC fund focused on Games, Esports and Digital Sports.
Partenaire indépendant en orchestration patrimoniale globale depuis 2007.
We are an innovative public-private partnership focused on social good.
We are a venture capital firm with operations in Prague and Luxembourg.
Please visit us at www.clastergroup.com. Thank you for your patience!
Early-stage VC focused on new AI solutions that replace human labor.
We provide funding and support to help your consumer startup thrive.
Pamoja Capital goes beyond the role of a simple financial partner.
Franco-Italian VC investing in innovative European tech startups.
We aim to transform healthcare through medical devices innovation
Investing in companies with exceptional long-term value potential
Aperam Ventures, a subsidiary of the steel company Aperam Group.
Accelerating the world's transition to blockchain technology.
Applied AI company building software to emulate human experts
We build value, create exits and reinvest into the ecosystem.
We are a venture capital fund specializing in life sciences.
SEC exempt reporting adviser to private funds.